SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-144386
Filing Date
2019-05-10
Accepted
2019-05-10 17:15:55
Documents
4
Period of Report
2019-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d747952d8k.htm 8-K 18446
2 EX-99.1 d747952dex991.htm EX-99.1 18838
3 GRAPHIC g747952g0511005609392.jpg GRAPHIC 4006
4 GRAPHIC g747952g0511005609548.jpg GRAPHIC 2355
  Complete submission text file 0001193125-19-144386.txt   47529
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 810930882 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38210 | Film No.: 19815994
SIC: 2836 Biological Products, (No Diagnostic Substances)